Hakiro Pharmaceuticals Private Limited
About Hakiro Pharmaceuticals Private Limited
Data last updated:
Hakiro Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 April 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2022PTC159858.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suman Kumar Singh (Managing Director) and Sameer Imam.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Taarvindar Keer Cabin – 202A #164 1st Cross 1st Stage Aecs Layout Sanjay Nagar, Bangalore, Karnataka, India – 560094.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.63 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹2,789 (net margin -1.7%) and EBITDA of ₹4,979 (EBITDA margin 3%).
Company details
Contact details
Hakiro Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressC/O Taarvindar Keer Cabin – 202A #164 1st Cross 1st Stage Aecs Layout Sanjay Nagar, Bangalore, Karnataka, India – 560094
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hakiro Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hakiro Pharmaceuticals Private Limited, buy the company report.
Financials of Hakiro Pharmaceuticals Private Limited
FY 2025 filings availableHakiro Pharmaceuticals Private Limited reported revenue of ₹1.63 Lakh (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year. EBITDA rose 19% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4,979 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2,789 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3% | ||
| Net Profit Margin | -1.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Hakiro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hakiro Pharmaceuticals Private Limited
Hakiro Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Kumar Singh | Managing Director | 09 Apr 2022 | 4 Years 6 Months | Current |
| Sameer Imam | Director | 09 Apr 2022 | 4 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Hakiro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hakiro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hakiro Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hakiro Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Sameer Imam was appointed as Director on 09 Apr 2022.
Frequently asked questions
Hakiro Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 April 2022 (4+ years old) and is registered under CIN U24290KA2022PTC159858.
Hakiro Pharmaceuticals has 2 current directors:
- Suman Kumar Singh - Managing Director
- Sameer Imam - Director
The latest financial statements of Hakiro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Hakiro Pharmaceuticals is U24290KA2022PTC159858. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hakiro Pharmaceuticals was incorporated on 09 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
Sameer Imam was appointed as Director on 09 Apr 2022. Suman Kumar Singh was appointed as Managing Director on 09 Apr 2022.
The registered office of Hakiro Pharmaceuticals is at CO Taarvindar Keer Cabin – 202A #164 1st Cross 1st Stage Aecs Layout Sanjay Nagar, Bangalore, Karnataka, India – 560094.
Hakiro Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Hakiro Pharmaceuticals can be reached at its registered office: CO Taarvindar Keer Cabin – 202A #164 1st Cross 1st Stage Aecs Layout Sanjay Nagar, Bangalore, Karnataka, India – 560094.
Hakiro Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.